ophthalmologytimes3 小时
ACELYRIN announces phase 2b/3 trial of izokibep did not meet primary endpoint, ceases ...
The phase 2b/3 clinical trial (NCT05683496) evaluated izokibep versus placebo in non-infectious, non-anterior uveitis.
The National on MSN2 小时
Abu Dhabi's new colon cancer blood test aims to boost early detection rates
Abu Dhabi health chiefs have hailed the introduction of a blood test for colon cancer as a "game-changer" in the emirate's ...